Same Drug Class

Ipilimumab vs Tacrolimus

Ipilimumab vs Tacrolimus: Overview

This comparison examines the pharmacological differences between Ipilimumab and Tacrolimus.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Tacrolimus: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Tacrolimus — 12 hours.

Chemical Properties

Molecular Formula: Tacrolimus — C44H69NO12.

Molecular Weight: Tacrolimus — 804.0180 g/mol.

Type: Ipilimumab — Antibody; Tacrolimus — Small molecule.